Anshan, China Clinical Trials

Diabetes Mellitus, Type 2

Investigational Site Number 156053

Patients are needed to participate in a clinical research study of INSULIN GLARGINE to evaluate Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)